// App-Quantinova.ai

446 : Pomalidomide Cyclophosphamide and Prednisone (PCP) Treatment for Relapsed/Refractory Multiple Myeloma

Researchers

Presenter

  • Alessandra Larocca

Principal Investigators

  • Vittorio Montefusco

  • Tommasina Guglielmelli

  • Nicola Giuliani

  • Giacinto La Verde

  • Ileana Baldi

  • Vittorio Emanuele Muccio

  • Mario Boccadoro

  • Paolo Corradini

  • Davide Rossi

  • Angelo Michele Carella

  • Roberto Mina

  • Claudia Crippa

  • Mariella Sciacca

  • Monica Galli

  • Delia Rota Scalabrini

  • Magda Marcatti

Medical Centers

  • Dipartimento Oncologico-D.O. Oncologia Medica a Direzione Universitaria, Fondazione del Piemonte per -Oncologia-IRCC, Candiolo, Italy

  • Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy, Novara, Italy

  • SC Ematologia e Dipartimento di Oncologia Clinica, A.O. Spedali Civili, Brescia, Italy

  • Unita Operativa di Onco-Ematologia, Ospedale S.Andrea, Vercelli, Italy

  • U.O.C. Ematologia 1, IRCCS A.O.U. San Martino-IST, Genova, Italy

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Department of Clinical and Biological Sciences, Division of Internal Medicine and Hematology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy

  • Unit of Cancer Epidemiology, Univerisity of Torino and CPO Piemonte, AOU S. Giovanni Battista, Torino, Italy

  • Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

  • U.O.S. Diagnosi e Cura delle Discrasie Plasmacellulari e delle Amiloidosi, A.O.SantAndrea, Sapienza University of Rome, Rome, Italy

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

  • Division of Hematology, Ospedali Riuniti, Bergamo, Italy

  • Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Thrombocytopenia

  • Venous thrombosis

  • Neutropenia

Biomarkers

  • Bone Morphogenetic Protein 1

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • Thalidomide

  • Bortezomib

  • Prednisone

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved